Blue Cross and Blue Shield
Dr. Ujjwal Ramtekkar, MD
Child & Adolescent Psychiatry*
Age 45
Be the first to review this provider!
Offers telehealth
Dr. Ujjwal Ramtekkar, MD
Be the first to review this provider!
Saint Louis, MO
Accepting new patients
Offers telehealth
Clinical Overview
Dr. Ujjwal Ramtekkar, MD works in Saint Louis, MO as
Offers Telehealth
This provider offers telehealth appointments. Call the office to schedule.
COMPARE OTHER TOP Child Psychiatrists
Contrast Dr. Ramtekkar with other nearby specialists.
These providers are on the medical staff of Talkspace.
Advertisement
Insurance & Payment Information
* Please verify this information when scheduling an appointment.
-
-
MultiPlan PPO
-
Medicaid
-
United Healthcare
-
Aetna
-
First Health (Coventry Health Care) PPO
-
Curative EPOCurative PPOCurative PPO Plus
-
Coventry Health Care
-
Health Net
Office Locations
-
Office621 S New Ballas Rd Ste 693A, Saint Louis, MO 63141
-
Solutions Counseling LLC252 Bradenton Ave, Dublin, OH 43017
-
Office6455 Post Rd, Dublin, OH 43016
-
Nationwide Children's Hospital700 Childrens Dr, Columbus, OH 43205
Patient Experience & Satisfaction
Be the first to leave a review
How likely are you to recommend Dr. Ramtekkar?
Step 1 of 3
Your review of Dr. Ujjwal Ramtekkar, MD
50 characters remaining
1000 characters remaining
Was this a Telehealth appointment?
(This will display with your review)
Your email is used to confirm your review and will NOT appear in the review.
This name will appear with your review. If left blank, we'll use "Anonymous".
RVO Health property, Medical News Today, is owned by RVO Health. Please review our terms of use for more.
Help other patients find the right care by sharing a few more details about your visit.
Last step! Confirm your email.
We've sent an email to
Once you confirm, you can close this window.
Thank you for your review!
Your review has been confirmed and will be published after verification.
Thank you for your review!
We've sent a confirmation email. Your review will appear after you confirm it.
Please allow up to 30 seconds for the email to arrive. Don't see it? Make sure to check your 'spam' and 'updates' folder. Once you've confirmed your review, you can close this window.
Medical Expertise & Background
Languages Spoken
Hindi
Marathi
Specialties*
Child & Adolescent Psychiatry
- *Medical News Today does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.
Common Patient Questions
Dr. Ujjwal Ramtekkar, MD accepts new patients on Medical News Today.
Dr. Ramtekkar accepts telehealth appointments. Please call Dr. Ramtekkar's office to make an appointment.
Dr. Ramtekkar accepts Blue Cross Blue Shield, MultiPlan, UnitedHealthCare, Aetna, First Health, Curative, Coventry Health Care and Health Net as well as many others. See all of the insurances Dr. Ramtekkar accepts here.
Dr. Ramtekkar's office is located at 621 S New Ballas Rd Ste 693A Saint Louis, MO 63141. Get a map and directions to Dr. Ramtekkar's office here.
Yes, Dr. Ramtekkar speaks Hindi and Marathi. See Dr. Ramtekkar's profile on MedicalNewsToday for more information.
Dr. Ramtekkar does not have any reviews yet.
Dr. Ramtekkar is board certified in
Education & Credentials
Board Certifications
- Child & Adolescent Psychiatry and Psychiatry
Internship
- Washington University School of Medicine
Residency Hospital
- Barnes-Jewish Hosp/Washington University Medical Center
Fellowship Hospital
- Children's Hospital Boston/Harvard Medical School
Claim Your Profile
Are you Dr. Ujjwal Ramtekkar, MD?
Telehealth Options
This provider has not specified a telehealth appointment method. Would you still like to make an appointment with Dr. Ramtekkar?
Affiliated Hospitals & Medical Centers
Know Before You Go
Preventive care: what doctors want you to know
Preventive care can help identify current or future health and medical concerns before they become major.
Featured Stories
Researchers have developed a new AI tool that could help predict the risk of distant breast cancer recurrence. In particular, it could help predict the risk of breast cancer returning 5 years or more after treatment.
The FDA has cleared two new blood tests for Alzheimer’s disease, Roche’s Elecsys pTau217 and C2N Diagnostics’ PrecivityAD2, which could help support earlier Alzheimer’s disease detection.
About one in five people who experienced a mini-stroke later received a dementia diagnosis, a new study has found.
